Hunt, Kelly K.

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

Mittendorf, E. A., Wu, Y., Scaltriti, M., Meric-Bernstam, F., Hunt, K. K., Dawood, S., Esteva, F. J., Buzdar, A. U., Chen, H., Eksambi, S., et al. (2009) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies

Cited by 330

CDK4/6 inhibitors sensitize rb-positive sarcoma cells to wee1 kinase inhibition through reversible cell-cycle arrest

Francis, A. M., Alexander, A., Liu, Y., Vijayaraghavan, S., Low, K. H., Yang, D., Bui, T., Somaiah, N., Ravi, V., Keyomarsi, K., et al. (2017) · Molecular Cancer Therapeutics

Sarcoma Diagnosis and TreatmentCancer-related Molecular Pathways

Cited by 54